Bristol-Myers Squibb Company (BMY)

56.49
-1.75(-3.00%)
After Hours
56.50
+0.01(+0.02%)
- Real-time Data
  • Volume:
    18,744,953
  • Bid/Ask:
    56.50/56.65
  • Day's Range:
    56.11 - 58.42

BMY Overview

Prev. Close
58.24
Day's Range
56.11-58.42
Revenue
44.38B
Open
58.35
52 wk Range
56.11-69.75
EPS
-2.27
Volume
18,744,953
Market Cap
125.53B
Dividend (Yield)
1.96
(3.37%)
Average Volume (3m)
9,476,399
P/E Ratio
-
Beta
0.59
1-Year Change
-3.83%
Shares Outstanding
2,222,113,553
Next Earnings Date
26 Oct 2021
What is your sentiment on Bristol-Myers Squibb Company?
or
Market is currently closed. Voting is open during market hours.

Bristol-Myers Squibb Company News

Bristol-Myers Squibb Company Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellSell
Technical IndicatorsSellSellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell

Bristol-Myers Squibb Company Company Profile

Bristol-Myers Squibb Company Company Profile

Employees
30250

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Abraxane, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Reyataz and Sustiva Franchise. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world. Its subsidiaries are Celgene Corp and MyoKardia, Inc.

Read More
  • Hello
    0
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.